We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Moberg Pharma Ab (publ) | LSE:0P48 | London | Ordinary Share | SE0003613090 | MOBERG PHARMA ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 30.45 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
STOCKHOLM, June 30, 2020 /PRNewswire/ -- During June 2020, the registered number of shares and votes in Moberg Pharma AB (OMX: MOB) ("Moberg Pharma" or the "Company") has increased due to conversion of convertible notes issued pursuant to the financing agreement entered into between the Company and Nice & Green S.A. on March 23rd, 2020.
The total number of shares and votes in the Company has increased as a result of the board of directors' resolution to approve Nice & Green S.A.'s request to convert a number of convertible notes into a total of 34,430 common shares in the Company, in accordance with the terms and conditions of the above mentioned financing agreement.At the date of this press release, the total number of shares in Moberg Pharma amounts to 19,257,940. All shares are common shares. The total number of votes is 19,257,940. At the date of this press release, the Company holds 554,746 own common shares.
About this information
The above information has been made public in accordance with the Swedish Financial Instruments Trading Act. The information was released for public distribution on June 30th 2020 at 8:00 am CET.
For additional information, please contact:
Anna Ljung
CEO
telephone: +46-707-66-60-30
e-mail: anna.ljung@mobergpharma.se
Mark Beveridge
VP Finance,
telephone: +46-76-805-82-88
e-mail: mark.beveridge@mobergpharma.se
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/moberg-pharma/r/new-number-of-shares-and-votes-in-moberg-pharma-ab--publ-,c3140979
The following files are available for download:
https://mb.cision.com/Main/1662/3140979/1269090.pdf | New number of shares and votes in Moberg Pharma AB (publ) |
View original content:http://www.prnewswire.com/news-releases/new-number-of-shares-and-votes-in-moberg-pharma-ab-publ-301085605.html
SOURCE Moberg Pharma
Copyright 2020 PR Newswire
1 Year Moberg Pharma Ab (publ) Chart |
1 Month Moberg Pharma Ab (publ) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
